MKS (MKSI) Q1 2026 Earnings Call Transcript

MKS delivered a strong Q1 with revenue of $1.08 billion (+15% YoY), gross margin of 47%, adjusted EBITDA of $277 million, and EPS of $2.30, all at or above the high end of guidance. Q2 outlook is also solid, with revenue guided to $1.2 billion ± $40 million and EPS of $2.90 ± $0.30, supported by AI-driven demand across semis and electronics & packaging, though tariff-related gross margin drag of 30-40 bps and palladium inflation remain headwinds. The company also raised its dividend 14% to $0.25 and maintains $1.5 billion of liquidity.

Analysis

MKS is emerging as a classic second-order AI beneficiary: not the GPU/wafer names that get the headlines, but the process-enabling picks-and-shovels that monetize every additional layer, interconnect, and packaging complication. The important shift is that demand is broadening from a cyclical upgrade story into a structural content-per-node story, which should allow MKSI to outgrow WFE even if the headline tool spend moderates. The Malaysia capacity build matters less as a near-term supply relief valve and more as a credibility anchor that removes execution risk just as customers are locking in multi-quarter programs.

The market may be underappreciating the mix effect. Chemistry and advanced packaging are becoming a larger share of the revenue stack, which increases visibility but also raises the chance that gross margin expansion will be lumpy if lower-margin equipment ramps faster than chemistry. In other words, the top line can accelerate faster than EPS in the next 1-2 quarters if the VSD and new capacity mix dilutes near-term margin, so the stock could get punished on a “good but not perfect” print despite the stronger medium-term thesis.

The real hidden catalyst is that MKS appears to be gaining share in areas where customer pain is highest: advanced DRAM/logic complexity, AI PCB warpage mitigation, and substrate bonding/yield. Those problems are not solved by simply spending more capex; they require process know-how, which supports pricing power and makes this cycle less vulnerable to pure commodity tool competition. The contrarian risk is not demand collapse, but a timing mismatch: if OEMs over-order into 2027 capacity or if consumer electronics weakens faster than AI chemistry grows, the company could see a digestion phase even while fundamentals remain intact.

Key Decisions for Investors

• Long MKSI on pullbacks over the next 2-4 weeks; use earnings/guidance strength as confirmation, but size for a 6-12 month hold because the rerating case depends on sustained AI content growth rather than one quarter of beat-and-raise.
• Pair long MKSI / short a more hardware-beta semi-capex beneficiary with weaker mix or less content-per-node exposure; thesis is MKSI’s higher attachment to process complexity should outperform if WFE flattens while AI packaging intensity rises.
• Buy MKSI Jan-2027 call spreads to express the Malaysia capacity + 2027 WFE ramp without paying full premium for near-term margin volatility; target is a multi-quarter expansion as capacity de-risks and mix improves.
• Avoid chasing the stock immediately after a strong guide if implied expectations reprice too quickly; the best entry is likely on any post-earnings de-rating caused by gross margin noise or consumer-electronics skepticism.
• For hedged books, consider a small short against a pure-play PCB or packaging beneficiary with less chemistry leverage; MKSI has more ways to compound if AI-driven layer counts keep rising.